Zoledronic-Acid-Induced Circulating Level Modifications of Angiogenic Factors, Metalloproteinases and Proinflammatory Cytokines in Metastatic Breast Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|69|1|35-43

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.1, 2005-09, pp. : 35-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK

By Guest Julian F.   Clegg John P.   Davie Alison M.   McCloskey Eugene  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 805-818

Informa Healthcare

Access to resources Recommend Favorite

Factors underlying metastatic breast cancer patients' perceptions of symptom importance: a qualitative analysis

By  

EUROPEAN JOURNAL OF CANCER CARE (ELECTRONIC), Vol. 27, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of Bevacizumab in Patients with Metastatic Breast Cancer

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 314-325

Karger

Access to resources Recommend Favorite

Effects of Simvastatin on Proinflammatory Cytokines and Matrix Metalloproteinases in Hypercholesterolemic Individuals

By Nilsson Lennart  

Inflammation, Vol. 34, Iss. 4, 2011-08 ,pp. : 225-230

Springer Publishing Company

Access to resources Recommend Favorite

Zoledronic Acid Induces a Significant Decrease of Circulating Endothelial Cells and Circulating Endothelial Precursor Cells in the Early Prostate Cancer Neoadjuvant Setting

By  

Oncology, Vol. 85, Iss. 6, 2013-12 ,pp. : 342-347

Karger

Access to resources Recommend Favorite